Appointments, promotions announced

Stanford Report, March 31, 2004

By JOYCE THOMAS

William Rhine, MD, was promoted to professor of pediatrics (neonatology). He is medical director in the neonatal intensive care unit and co-director of the extracorporeal membrane program at Lucile Packard Children's Hospital.

Rhine's research focuses on basic and clinical investigation of problems encountered in neonatology. He is co-principal investigator on two nitric oxide studies and principal investigator on an ongoing trial to reduce chronic lung disease in premature newborns. He is a member of the California Perinatal Quality Care Collaborative and president-elect of the California Association of Neonatologists.

Rhine received his medical degree in 1984 and completed an internship and residency in pediatrics followed by a fellowship in neonatal-perinatal medicine, all at Stanford. He was appointed to the faculty in 1990.

Krisa Van Meurs, MD, was promoted to professor of pediatrics (neonatology). Van Meurs co-directs the extracorporeal membrane oxygenation program at Packard Hospital and serves as associate director of Packard nurseries at the Johnson Center for Pregnancy and Newborn Services.

Van Meurs is the principal investigator of an ongoing multicenter clinical trial on the use of inhaled nitric oxide for preterm infants with severe respiratory failure. She is on the steering committee and chair of the communication committee of the Extracorporeal Life Support Organization, an international consortium of health-care professionals and scientists.

Van Meurs received her medical degree in 1981 from George Washington University. She completed a pediatric residency, served as chief pediatrics resident and as a postdoctoral scholar at Children's National Medical Center, Washington, D.C. Van Meurs joined Stanford in 1990.

Paul J. Wang, MD, was appointed professor of medicine (cardiovascular medicine). Wang directs the cardiac arrhythmia service and cardiac electrophysiology laboratory at the medical center.

He is a pioneer in the development of techniques and devices for diagnosing and treating arrhythmias. He became a fellow of the American College of Cardiology in 1991.

Wang graduated from the College of Physicians and Surgeons, Columbia University, in 1983. His postdoctoral training included an internship and residency in internal medicine at Presbyterian Hospital, New York, and a fellowship in cardiovascular diseases at Brigham & Women's Hospital, Boston. From 1989 to 2003 he was associate director of the ccardiac electrophysiology and pacemaker laboratory, New England Medical Center, and served on the faculty at Tufts University. Wang joined Stanford in June.

Alan C. Yeung, MD, was promoted to professor of medicine (cardiovascular). He is chief of the division of cardiovascular medicine (clinical) and director of the cardiac catheterization and interventional laboratories.

His scholarly work focuses on treatment for atherosclerosis of the coronary arteries. He is a pioneer in the development of minimally invasive coronary revascularization, opening blood vessels to improve blood flow to the heart, and new approaches to the problem of restenosis, or re-narrowing of an artery.

Yeung is principal investigator of numerous clinical trials, including a new study of an innovative technique for delivering cardiac drug therapy.

He is board-certified in internal medicine, cardiovascular disease and interventional cardiology.

Yeung received his MD from Harvard in 1984. After an internship and residency in medicine at Massachusetts General Hospital, he completed a clinical fellowship at Brigham & Women's Hospital and a research fellowship at Harvard, both in cardiology. He joined the Stanford faculty in 1993.